Tag: matinas biopharma

October 18, 2018

Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001

Matinas BioPharma (NYSE:MTNB), a clinical-stage biopharmaceutical company, announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,058,521...
July 9, 2018

NIH and Matinas BioPharma Announce Research Collaboration to Identify Novel HIV Therapy Utilizing LNC Platform Delivery Technology

Matinas BioPharma (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative medicines using its proprietary lipid nano-crystal (LNC) platform delivery...